# Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use

> **NCT02744040** · NA · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 151 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** ART initiation at time of HIV diagnosis
- **DRUG:** ART at 24 weeks

## Key facts

- **NCT ID:** NCT02744040
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-28
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-11-30
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2022-03-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02744040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02744040, "Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02744040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*